Anesthetic barbiturates in refractory status epilepticus

Area of Science:

• Neurology
• Critical Care Medicine

Background:

• Status epilepticus (SE) is a neurological emergency characterized by prolonged or recurrent seizures.
• Refractory SE (RSE) occurs when seizures persist despite adequate treatment with first- and second-line anticonvulsant medications.

Observation:

• Two patients with prior cerebral damage and seizures and three with acute inflammatory cerebral lesions presented with status epilepticus.
• These patients were refractory to conventional anticonvulsant therapies.

Findings:

• Prompt cessation of status epilepticus was achieved using anesthetic barbiturates, specifically thiopental and pentobarbital.
• Anesthetic barbiturates demonstrated efficacy in controlling seizures that were unresponsive to standard anticonvulsant agents.

Implications:

• Anesthetic barbiturates represent a viable therapeutic option for managing refractory status epilepticus.
• These findings suggest a crucial role for barbiturates in the treatment algorithm for severe, intractable seizure emergencies.